The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
COMy 2023 | The changing role of autoSCT in the treatment of multiple myeloma in the era of novel agents
In this video, Eileen Boyle, MD, PhD, University College London, London, UK, comments on how the treatment landscape of multiple myeloma has transformed over the years, emphasizing the changing role of autologous stem cell transplantation (autoSCT) in the era of novel agents. This interview took place at the 9th World Congress on Controversies in Multiple Myeloma (COMy) 2023, held in Paris, France.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
